Cord Blood America, Inc. Announces Agreement to Sell Substantially All of Its Assets to FamilyCord
February 7, 2018 - Cord Blood America, Inc. (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") announced today that it has entered into an agreement with California Cryobank Stem Cell Services LLC (dba “FamilyCord”) for the sale of substantially all of its assets to FamilyCord for a purchase price of $15.5 million.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.